ICU Medical, Inc. (ICUI)

NASDAQ: ICUI · USD

$166

+2.92 (+1.8%)· Recorded snapshot

Market cap	4.2B
Revenue (ttm)	2.2B
Net income (ttm)	30.1M
EPS (ttm)	$1.20
Shares out	25M
P/E (trailing)	138.0x
P/E (forward)	53.5x
Volume	119,916
Beta	0.87

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.2B
Net income (ttm): 30.1M
EPS (ttm): $1.20
P/E (trailing): 138.0x
P/E (forward): 53.5x
Market cap: 4.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E53.5

P25 n/aP50 n/aP75 n/a

Trailing P/E138

P25 n/aP50 n/aP75 n/a

ROE1.4

P25 n/aP50 n/aP75 n/a

ROIC4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ICUI indicators

Market & fundamental data

Available fields

265

Groups with data

Currency

USD

Showing 265 of 265 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000883984
Company name	ICU Medical, Inc.
Country	United States
Country code	US
CUSIP number	44930G107
Earnings date	2026-11-05
Earnings time	amc
Employees	13,000
Employees change	-2,000
Employees growth	-13.33%
Enterprise value	$5.1B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1984
In index	RUSSELL2000
Industry	Medical Instruments & Supplies
IPO date	1992-03-31
Is primary listing	Yes
Is SPAC	No
ISIN number	US44930G1076
Last 10-K release date	2026-02-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2002-03-18
Last stock split type	Forward
Market cap	$4.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$166.12
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	ICUI
U.S. state	California
Website	https://www.icumed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	20.06x
Average P/E ratio (10Y)	276.52x
Earnings yield	0.72%
EV/Earnings	170.19x
EV/EBIT	41.01x
EV/EBITDA	15.7x
EV/FCF	33.51x
EV/Sales	2.37x
FCF / EV yield	2.98%
FCF yield	3.69%
Forward EV/Sales	2.3x
Forward P/E	53.48x
Forward P/S	1.85x
Graham number	48.2752
Graham upside	-70.81%
Industry forward P/E	22.69x
Industry P/E	75.18x
Lynch fair value	$6.02
Lynch upside	-96.36%
P/(FCF - SBC) ratio	42.28x
P/(OCF - SBC) ratio	22.81x
P/B ratio	1.9x
P/E ratio	138.01x
P/FCF ratio	27.06x
P/OCF ratio	17.5x
P/S ratio	1.92x
PEG ratio	4.82x
Price / tangible book value	41.44x
Price/EBITDA ratio	12.68x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.78%
EBITDA margin	15.1%
FCF margin	7.08%
Gross margin	38.26%
Operating margin	5.78%
Pretax margin	-0.04%
Profit margin	1.39%
Profit per employee	$2,315
Profitable quarters	2
Profitable years	1
Revenue per employee	$166,123
ROA	1.93%
ROA (5Y)	1.71%
ROCE	3.6%
ROE	1.41%
ROE (5Y)	-0.9%
ROIC	3.96%
ROIC (5Y)	3.08%
SBC / revenue	2.55%
Tax / revenue	-1.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-46.85%
EPS growth (QoQ)	-36.67%
EPS growth 10Y	-9.75%
EPS growth 5Y	-24.04%
EPS growth years	1
FCF growth	152.53%
FCF growth (QoQ)	123.27%
FCF growth 5Y	-2.88%
Gross profit growth	-2.83%
Gross profit growth (Q)	3.89%
Gross profit growth 3Y	3.48%
Gross profit growth 5Y	11.94%
Net income growth (Q)	-45.99%
Net income growth (QoQ)	-36.66%
Net income growth 5Y	-21.86%
Net income growth years	1
OCF growth	70.26%
OCF growth (Q)	614.92%
OCF growth (QoQ)	105.99%
OCF growth 10Y	11.9%
OCF growth 3Y	80.24%
OCF growth 5Y	-1.89%
Operating income growth	1.05%
Operating income growth (Q)	54.93%
Operating income growth 3Y	29.69%
Operating income growth 5Y	-1.59%
Revenue growth	-8.97%
Revenue growth (Q)	0.51%
Revenue growth (QoQ)	4.05%
Revenue growth 10Y	19.59%
Revenue growth 3Y	-1.99%
Revenue growth 5Y	11.05%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-83.5M
Depreciation and amortization	$201.3M
EBIT	$124.9M
EBITDA	$326.1M
EPS	$1.20
FCF per share	$6.11
Financing cash flow	$-154.5M
Free cash flow	$152.8M
Free cash flow minus SBC	$97.8M
Gross profit	$826.2M
Income taxes	$-31M
Investing cash flow	$-79.8M
Net borrowing	$-111.8M
Net cash flow	$-1.7M
Net income	$30.1M
Operating cash flow minus SBC	$181.4M
Operating income	$124.9M
Revenue	$2.2B
Stock-based compensation	$55M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.21
Book value per share	$86.05
Debt / EBITDA	3.76
Debt / equity	0.6
Debt / FCF	8.42
Goodwill	$1.5B
Interest coverage	1.52
Long-term assets	$2.8B
Long-term liabilities	$1.3B
Net cash (debt)	$-984.5M
Net cash / market cap	-23.8%
Net debt / EBITDA	3.02
Net debt / equity	0.46
Net debt / FCF	6.44
Piotroski F-Score	6
Property, plant and equipment	$491.3M
Shareholders' equity	$2.2B
Tangible book value	$99.8M
Tangible book value per share	$3.99
Total assets	$4B
Total cash	$302.6M
Total debt	$1.3B
Total liabilities	$1.8B
WACC	8.07%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	$1.2B
Current liabilities	$498.4M
Current ratio	2.43
Inventory turnover	2.18
Net working capital	$444.2M
Quick ratio	1
Working capital	$712.5M
Working capital turnover	3.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.28%
Dividend yield	0%
Shareholder yield	-2.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	18.15%
10Y return CAGR	1.68%
10Y total return	18.15%
150-day SMA	$149.73
15Y price change	307.63%
15Y return CAGR	9.82%
15Y total return	307.63%
1D price change	1.79%
1M price change	-0.51%
1M total return	-0.51%
1W price change	1.88%
1W total return	1.88%
1Y price change	33.52%
1Y return CAGR	33.55%
1Y total return	33.52%
20-day SMA	$162.13
200-day SMA	$148.41
20Y price change	279.71%
20Y return CAGR	6.9%
20Y total return	279.71%
3M price change	1.64%
3M total return	1.64%
3Y price change	64.8%
3Y return CAGR	18.12%
3Y total return	64.8%
50-day SMA	$164.92
50-day SMA vs 200-day SMA	50over200
52-week high	$192.85
52-week high date	2026-08-07
52-week low	$113.37
52-week low date	2026-04-29
5Y price change	-27.83%
5Y return CAGR	-6.32%
5Y total return	-27.83%
6M price change	33.59%
6M total return	33.59%
All-time high	$321.70
All-time high date	2018-08-10
All-time low	$3.00
All-time low date	1992-04-27
Average true range (ATR)	$4.98
Average volume	213.4K
Beta (1Y)	0.96
Beta (2Y)	0.77
Beta (5Y)	0.87
Change from 52-week high	-13.86%
Change from 52-week low	46.53%
Change from all-time high	-48.99%
Change from all-time low	5,370.33%
Change from open	0.34%
Day's gap	1.45%
Dollar volume	$19.9M
High price	$166.12
Low price	$164.73
Monthly RSI	56.44
Open price	$165.56
Position in 52-week range	100%
Previous close	$163.20
Price vs 150-day SMA	9.61%
Price vs 20-day SMA	1.22%
Price vs 200-day SMA	10.58%
Price vs 50-day SMA	-0.49%
Relative volume	0.56
RSI	51.6
Sharpe ratio	0.88
Sharpe ratio (3Y)	0.46
Sharpe ratio (5Y)	-0.07
Sortino ratio	1.64
Sortino ratio (3Y)	0.86
Sortino ratio (5Y)	0.04
Volume	119.9K
Weekly RSI	55.15
YTD price change	15.03%
YTD total return	15.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24.6M
Float percentage	98.2%
Shares change (QoQ)	-0.55%
Shares change (YoY)	2.28%
Shares held by insiders	1.77%
Shares held by institutions	105.48%
Shares outstanding	25M
Short % of float	6.2%
Short % of shares	6.09%
Short ratio	5.8 days

Deeper analysis on ICUI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ICUI report

Is a complete ICUI research report available?

No complete published report is available for ICU Medical, Inc. (ICUI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ICU Medical, Inc. (ICUI)

Price

Financial snapshot

Fair-value bridge

Latest news · ICUI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ICUI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ICUI

Frequently asked questions